Patents by Inventor Romain Cayrol

Romain Cayrol has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITION OF TH17 CELLS MIGRATION TO INFLAMED TISSUES USING ANTIBODIES DIRECTED AGAINST MCAM
    Publication number: 20150218266
    Abstract: Methods, uses, agents and compositions useful for the diagnosis, prevention and/or treatment of inflammatory conditions, such as neuroinflammatory conditions such as multiple sclerosis, and for the identification and selection of inflammatory cytokine-secreting T cell or a precursor thereof, based on the expression and/or modulation of melanoma cell adhesion molecule (MCAM) are disclosed.
    Type: Application
    Filed: April 23, 2015
    Publication date: August 6, 2015
    Inventors: ALEXANDRE PRAT, ROMAIN CAYROL, NATHALIE ARBOUR
  • Treatment of neuroinflammatory conditions using antibodies directed against MCAM
    Patent number: 9017682
    Abstract: Methods, uses, agents and compositions useful for the diagnosis, prevention and/or treatment of inflammatory conditions, such as neuroinflammatory conditions such as multiple sclerosis, and for the identification and selection of inflammatory cytokine-secreting T cell or a precursor thereof, based on the expression and/or modulation of melanoma cell adhesion molecule (MCAM) are disclosed.
    Type: Grant
    Filed: September 14, 2012
    Date of Patent: April 28, 2015
    Assignee: Val-Chum, Limited Partnership
    Inventors: Alexandre Prat, Romain Cayrol, Nathalie Arbour
  • MCAM MODULATION AND USES THEREOF
    Publication number: 20130017206
    Abstract: Methods, uses, agents and compositions useful for the diagnosis, prevention and/or treatment of inflammatory conditions, such as neuroinflammatory conditions such as multiple sclerosis, and for the identification and selection of inflammatory cytokine-secreting T cell or a precursor thereof, based on the expression and/or modulation of melanoma cell adhesion molecule (MCAM) are disclosed.
    Type: Application
    Filed: September 14, 2012
    Publication date: January 17, 2013
    Applicant: CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
    Inventors: ALEXANDRE PRAT, ROMAIN CAYROL, NATHALIE ARBOUR, CATHERINE LAROCHELLE
  • MCAM modulation and uses thereof
    Patent number: 8293468
    Abstract: Methods, uses, agents and compositions useful for the diagnosis, prevention and/or treatment of inflammatory conditions, such as neuroinflammatory conditions such as multiple sclerosis, and for the identification and selection of inflammatory cytokine-secreting T cell or a precursor thereof, based on the expression and/or modulation of melanoma cell adhesion molecule (MCAM) are disclosed.
    Type: Grant
    Filed: June 9, 2010
    Date of Patent: October 23, 2012
    Assignee: Centre Hospitalier de l'Université de Montréal
    Inventors: Alexandre Prat, Romain Cayrol, Nathalie Arbour, Catherine Larochelle
  • MCAM MODULATION AND USES THEREOF
    Publication number: 20110014183
    Abstract: Methods, uses, agents and compositions useful for the diagnosis, prevention and/or treatment of inflammatory conditions, such as neuroinflammatory conditions such as multiple sclerosis, and for the identification and selection of inflammatory cytokine-secreting T cell or a precursor thereof, based on the expression and/or modulation of melanoma cell adhesion molecule (MCAM) are disclosed.
    Type: Application
    Filed: June 9, 2010
    Publication date: January 20, 2011
    Inventors: ALEXANDRE PRAT, ROMAIN CAYROL, NATHALIE ARBOUR, CATHERINE LAROCHELLE